2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one
C23H36O6 — CID 70843888
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one
2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one (PubChem CID 70843888) has the molecular formula C23H36O6 and a molecular weight of 408.54 g/mol. Its IUPAC name is 2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one.
Molecular Properties
| Compound Name | 2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one |
|---|---|
| PubChem CID | 70843888 |
| Molecular Formula | C23H36O6 |
| Molecular Weight | 408.54 g/mol |
| Exact Mass | 408.25 |
| IUPAC Name | 2-dodecyl-5-hydroxy-6-(3,4,5-trihydroxycyclohexa-1,5-dien-1-yl)-2,3-dihydropyran-4-one |
| SMILES | CCCCCCCCCCCCC1CC(=O)C(O)=C(C2=CC(O)C(O)C(O)=C2)O1 |
| InChI | InChI=1S/C23H36O6/c1-2-3-4-5-6-7-8-9-10-11-12-17-15-20(26)22(28)23(29-17)16-13-18(24)21(27)19(25)14-16/h13-14,17-18,21,24-25,27-28H,2-12,15H2,1H3 |
| InChIKey | MZYJXIADRGKCCX-UHFFFAOYSA-N |
| XLogP | 4.53 |
| TPSA | 107.22 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.54 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70843888 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.